Genflow Strengthens IP Portfolio
Genflow Strengthens Global IP Portfolio with China Patent Examination Filing for SIRT6 Variants in NASH LONDON, UK / ACCESS Newswire...
Genflow Strengthens Global IP Portfolio with China Patent Examination Filing for SIRT6 Variants in NASH LONDON, UK / ACCESS Newswire...
WINSTON-SALEM, N.C., Sept. 18, 2025 /PRNewswire/ -- Inmar Intelligence, a leader in healthcare technology and compliance solutions, has been awarded...
IBYC, based in Richmond, BC, is a next-generation digital health company developing AI-powered telemedicine and wearable solutions to improve access...
The addition of Blue Spark Technologies, Inc. and QT Medical as device partners signals exciting growth for HeartcoR Solutions as...
Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene silencing' medicines...
In this free webinar, gain insight into the core principles and current capabilities of non-covalent and covalent DNA-Encoded Library (DEL)...
Kevin R. Hanz, MD: Dallas' Choice for Best in Cosmetic Surgery, Liposuction, and Breast Augmentation DALLAS, TX / ACCESS Newswire...
Criteria updates include new AI program, cyber resilience recommendations WASHINGTON, DC / ACCESS Newswire / September 18, 2025 / DirectTrust®,...
MESA, ARIZONA / ACCESS Newswire / September 18, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a leader in AI-powered...
DENVER, CO AND MAHWAH, NJ / ACCESS Newswire / September 18, 2025 / ForCast Orthopedics, Inc. and KORU Medical Systems,...
After treating 50,000+ patients abroad, the Norwegian startup closes $4.5M seed round, opens U.S. headquarters, and launches Acne Care app....
Rethink Impact leads investment round as company targets expansion to 30+ states by end of 2026 WASHINGTON, DC / ACCESS...
New in vitro results show Telomir-1 adds KDM5 family inhibition to its previously reported KDM2/KDM6 and DNA methylation activity, potentially...
The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a...
TAMPA, FLORIDA / ACCESS Newswire / September 18, 2025 / The America's Best Plastic Surgeons in America 2025 list from...
Intellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the...
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
Donnelly brings more than 25 years of biopharmaceutical expertise in CMC and regulatory operationsSEATTLE and VANCOUVER, British Columbia, Sept. 18,...
SANTA ANA, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage...
5-year UG3/UH3 grant will fund the optimization and early-stage development of atai’s novel 5-HT2A/2C receptor agonists with non-hallucinogenic potential for...